176 related articles for article (PubMed ID: 29924446)
1. Significance of pSmad2/3 and Smad4 in hepatitis C virus-related liver fibrosis and hepatocellular carcinoma.
Moussa MM; Helal NS; Youssef MM
APMIS; 2018 Jun; 126(6):477-485. PubMed ID: 29924446
[TBL] [Abstract][Full Text] [Related]
2. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.
Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N
APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457
[TBL] [Abstract][Full Text] [Related]
3. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
Abdelaziz AO; Shousha HI; Said EM; Soliman ZA; Shehata AA; Nabil MM; Abdelmaksoud AH; Elbaz TM; Abdelsalam FM
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1384-1388. PubMed ID: 30179227
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study.
Hatzakis A; Katsoulidou A; Kaklamani E; Touloumi G; Koumantaki Y; Tassopoulos NC; Karvountzis G; Gioustozi A; Hadziyannis S; Trichopoulos D
Int J Cancer; 1996 Sep; 68(1):51-3. PubMed ID: 8895540
[TBL] [Abstract][Full Text] [Related]
7. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.
Yamaguchi T; Yoshida K; Murata M; Matsuzaki K
World J Gastroenterol; 2014 Sep; 20(35):12381-90. PubMed ID: 25253939
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
10. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
[TBL] [Abstract][Full Text] [Related]
11. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.
El-Bassiouni NE; Nosseir MM; Madkour ME; Zoheiry MM; Bekheit IW; Ibrahim RA; Ibrahim IM; El Bassiouny AE
Mol Biol Rep; 2012 Jun; 39(6):6843-50. PubMed ID: 22318548
[TBL] [Abstract][Full Text] [Related]
12. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
13. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
14. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
Nomair AM; Kandil LS; Nomeir HM; Kandil NS
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
[TBL] [Abstract][Full Text] [Related]
17. Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.
El Bassiouny AE; El-Bassiouni NE; Nosseir MM; Zoheiry MM; El-Ahwany EG; Salah F; Omran ZS; Ibrahim RA
Medscape J Med; 2008 Jun; 10(6):130. PubMed ID: 18679533
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hashad DI; Elyamany AS; Salem PE
Genet Test Mol Biomarkers; 2015 Nov; 19(11):604-9. PubMed ID: 26447820
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
20. Smad4 expression in hepatocellular carcinoma differs by hepatitis status.
Yao L; Li FJ; Tang ZQ; Gao S; Wu QQ
Asian Pac J Cancer Prev; 2012; 13(4):1297-303. PubMed ID: 22799322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
